Accolade (ACCD) said Wednesday it has agreed to be acquired by Transcarent for $7.03 per share, which it said represents a total equity value of approximately $621 million.
The companies said the acquisition price represents a premium of approximately 110% over Accolade's Tuesday closing stock price.
The companies said Transcarent will finance the transaction through equity financing led by General Catalyst and Glen Tullman's 62 Ventures.
The boards of directors of both companies have unanimously approved the deal, which is expected to close in Q2 following stockholder and regulatory approvals and other customary closing conditions. Upon completion, Accolade will become a privately held company and its stock will no longer be listed on Nasdaq, the companies said.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。